20200120163240asfjn3
20200120163240asfjn3

Sapropterin Dihydrochloride

Product：Sapropterin Dihydrochloride
Indication：Reduce blood phenylalanine (Phe) levels in patients with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive Phenylketonuria (PKU).
Specification：In-house
Regulatory status：US, China, Taiwan
BACK BACK